2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994




    

 


Company Abstracts  ::  2000

2000 Presentation Abstracts   2000 Publications Abstracts


SLE TRIAL SHOWS FEWER RENAL FLARES IN LJP 394-TREATED PATIENTS WITH HIGH-AFFINITY ANTIBODIES TO LJP 394: 90-05 TRIAL RESULTS.
D. Alarcon-Segovia, et al.
Presented at the
64th Annual Scientific Meeting of the American College of Rheumatology
Philadelphia, PA.
Oct. 29 - Nov. 2, 2000


EFFECT OF LJP 394 ON PATIENTS WITH GREATEST IMPAIRMENT OF RENAL FUNCTION AT BASELINE IN THE 90-05 TRIAL.
Matthew D. Linnik, et al.
Presented at the
64th Annual Scientific Meeting of the American College of Rheumatology
Philadelphia, PA.
Oct. 29 - Nov. 2, 2000


AFFINITY OF ANTIBODIES FOR LJP 394 INFLUENCES PHARMACODYNAMIC RESPONSE TO LJP 394 IN SLE PATIENTS WITH POSITIVE dsDNA ANTIBODY TITERS.
Matthew D Linnik, et al.
Presented at the
64th Annual Scientific Meeting of the American College of Rheumatology
Philadelphia, PA.
Oct. 29 - Nov. 2, 2000


LUPUS PATIENT PHARMACODYNAMIC RESPONSE TO LJP 394 IS
INFLUENCED BY PRE-TREATMENT ANTIBODY AFFINITY FOR LJP 394
Patricia A. McNeeley, et al.
Presented at
The 26th Annual Conference of the La Jolla Immunologists
La Jolla, California
October 24-25, 2000


PHARMACOKINETICS AND POTENCY OF TOLERAGENIC COMPOUNDS: SCREENING OF CANDIDATE COMPOUNDS FOR THE TREATMENT OF ANTIPHOSPHOLIPID SYNDROME
Eric M. Smith, et al.
Presented at
The 26th Annual Conference of the La Jolla Immunologists
La Jolla, California
October 24-25, 2000


USE OF SINGLE POINT MUTATIONS IN DOMAIN 1 OF b2GPI TO DETERMINE FINE ANTIGENIC SPECIFICITY OF ANTIPHOSPHOLIPID AUTOANTIBODIES.
G. Michael Iverson, et al.
Presented at
The 9th International Symposium on Antiphospholipid Antibodies
Tours, France
September 12-16, 2000

Also presented at the
26th Annual Conference of the La Jolla Immunologists
October 24-25, 2000
La Jolla, California, USA



TOLERANCE ACTIVITY AND PHARMACOKINETICS OF MULTIVALENT b2GP1 DOMAIN ONE CONJUGATES IN AN IMMUNIZED ANIMAL MODEL.
Michael J. Branks, et al.
Presented at
The 9th International Symposium on Antiphospholipid Antibodies
Tours, France
September 12-16, 2000


REDUCTION IN ANTI-dsDNA ANTIBODIES BY LJP 394 IN LUPUS PATIENTS IS INFLUENCED BY AFFINITY FOR THE LJP 394 dsDNA EPITOPE.
Matthew D. Linnik, et al.
Presented at the
Keystone Symposia 2000 "Mechanisms of Immunologic Tolerance and its Breakdown,"
Steamboat Springs, CO
March 31-April 6, 2000






A CONVENIENT SYNTHESIS OF N-(TERT-BUTYLOXYCARBONYL) AMINOOXY ETHERS.
David S. Jones, et al.
Published in
Tetrahedron Letters
41 (2000) 1531-1533




Terms of Use & Privacy Policy
Copyright © 2007, La Jolla Pharmaceutical Company